AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Cramer's Morning Take: Bristol Myers & Eli Lilly 11/25/24
Squawk on the Street
Investment Insights: Bristol-Myers and Its Game-Changing Schizophrenia Drug
This chapter explores Bristol-Myers' new schizophrenia drug and its potential impact on investment portfolios. It also examines upcoming patent cliffs and their projected effects on earnings by 2028, placing the discussion within the larger context of pharmaceutical investments.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode